查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596769

基質血管成分市場：依產品、應用和最終用途 – 2025-2030 年全球預測

Stromal Vascular Fraction Market by Product (Aspiration, Isolation, Transfer), Application (Cosmetic, Orthopedic, Soft Tissue), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基質血管成分市場價值為37144萬美元，預計2024年將達到51694萬美元，複合年成長率為39.65%，到2030年將達到384895萬美元。

基質血管成分（SVF）是指源自脂肪組織的一組細胞，含有豐富的再生細胞，如間質幹細胞、內皮細胞和免疫細胞。 SVF 的範圍涵蓋其在再生醫學、美容學以及在治療各種疾病中的潛在應用的重要作用。對 SVF 的需求在於其透過其豐富的細胞成分促進癒合和組織再生的能力。它具有廣泛的應用，包括用於脂肪移植和組織增強的美容醫學、促進關節再生的整形外科手術以及被認為有望促進心肌再生的心臟病學。最終用途範圍主要涵蓋醫療機構、研究機構和整容手術中心。慢性疾病患者數量的增加、醫療基礎設施的進步以及對高效微創治療解決方案的需求不斷成長推動了市場成長。最近的趨勢包括使用 SVF 開發神經退化性疾病的治療方法並將其應用擴展到新的治療領域。希望利用這些機會的研究人員包括投資使用 SVF 的新治療方法的研究、加強生物技術公司和醫療保健提供者之間的合作以及提高監管合規性以簡化市場准入。

主要市場統計
基準年[2023] 37144萬美元
預測年份 [2024] 51694萬美元
預測年份 [2030] 38.4895億美元
複合年成長率（%） 39.65%

然而，挑戰依然存在，包括因嚴格的安全標準和不同地區的合規要求而導致的監管障礙。此外，SVF 治療還存在一些局限性，例如成本高、醫療保健提供者和患者缺乏認知和理解。改進 SVF 萃取技術和配製人工支架材料以增強細胞輸送和整合的創新已經成熟。最佳化 SVF 細胞儲存和運輸系統的研究也有望實現業務成長。市場是動態的，其特點是快速的技術進步和不斷變化的監管環境，要求企業保持敏捷性和適應性，以維持成長和創新。

市場動態：揭示快速發展的基質血管成分市場的關鍵市場洞察

供需的動態交互作用正在改變基質血管成分市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 再生醫學臨床前和臨床研究的增加
    • 骨關節炎和軟骨再生等各種疾病的手術數量增加
    • 燒燙傷和皮膚病增加
  • 市場限制因素
    • SVF手術器械成本高
  • 市場機會
    • 技術創新為SVF推出新產品
    • 持續策略投資以有效管理靜脈注射
  • 市場挑戰
    • 技術純熟勞工短缺和產品召回

波特的五力：駕馭基質血管成分市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基質血管成分市場的外部影響

外部宏觀環境因素在塑造基質血管成分市場的表現動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基質血管成分市場的競爭格局

對基質血管成分市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質血管成分市場供應商的績效評估

FPNV定位矩陣是評估基質血管成分市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃基質血管成分市場的成功之路

基質血管成分市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加再生醫學臨床前和臨床研究的調查
      • 骨關節炎、軟骨再生等各種疾病的手術增多
      • 燒燙傷和皮膚病增加
    • 抑制因素
      • SVF手術器械高成本
    • 機會
      • 技術創新，發布SVF新產品
      • 持續策略投資以有效管理靜脈輸液
    • 任務
      • 技術純熟勞工短缺和產品召回
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基質血管成分市場：依產品

  • 慾望
  • 分離
  • 轉移

第7章基質血管成分市場：依應用分類

  • 化妝品
  • 整形外科
  • 軟組織

基質血管成分市場：依最終用途

  • 醫院
  • 專科診所
  • 幹細胞庫/實驗室

第9章北美和南美基質血管成分市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區基質血管成分市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲基質血管成分市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Cytori Therapeutics Inc.
  • Hawaii Angels
  • Human Med AG
  • InGeneron, Inc.
  • Tissue Genesis
Product Code: MRR-9B479F385089

The Stromal Vascular Fraction Market was valued at USD 371.44 million in 2023, expected to reach USD 516.94 million in 2024, and is projected to grow at a CAGR of 39.65%, to USD 3,848.95 million by 2030.

Stromal Vascular Fraction (SVF) refers to a cluster of cells derived from adipose tissue, containing a rich assortment of regenerative cells, including mesenchymal stem cells, endothelial cells, and immune cells. The scope of SVF encompasses its significant role in regenerative medicine, aesthetics, and potentially, therapeutic applications for various diseases. The necessity of SVF springs from its capability to promote healing and tissue regeneration due to its rich cellular components. Applications are widespread, particularly in aesthetic medicine for fat grafting and tissue augmentation, orthopedics to encourage joint regeneration, and cardiology, where it has shown promise in myocardial regeneration. End-use scope primarily spans healthcare facilities, research institutes, and cosmetic surgery centers. Market growth is driven by increasing cases of chronic diseases, advancements in healthcare infrastructure, and an escalating demand for efficient, minimally invasive therapeutic solutions. Recent opportunities lie in harnessing SVF for developing treatments for neurodegenerative disorders and expanding its application across new therapeutic domains. Recommendations to leverage these opportunities include investing in research for novel SVF-based therapies, enhancing collaborations between biotech companies and healthcare providers, and focusing on regulatory compliance to ease market entry.

KEY MARKET STATISTICS
Base Year [2023] USD 371.44 million
Estimated Year [2024] USD 516.94 million
Forecast Year [2030] USD 3,848.95 million
CAGR (%) 39.65%

However, challenges persist such as regulatory hurdles due to stringent safety standards and varying compliance requirements across regions. Additionally, the market faces limitations like the high cost of SVF therapy procedures and a potential lack of awareness and understanding among healthcare providers and patients. Innovations are ripe in improving SVF extraction techniques and formulating artificial scaffold materials that enhance cell delivery and integration. Research in optimizing storage and transportation systems for SVF cells also promises business growth. The market is dynamic, characterized by rapid technological advancements and an evolving regulatory landscape, necessitating companies to stay agile and adaptable to sustain growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stromal Vascular Fraction Market

The Stromal Vascular Fraction Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research in pre-clinical and clinical investigations for regenerative medicine
    • Rising surgeries for different diseases, including osteoarthritis and cartilage regeneration
    • Growing cases of burn and skin diseases
  • Market Restraints
    • High costs of surgical devices for SVF
  • Market Opportunities
    • Technological innovations for new product launches for SVF
    • Ongoing strategic investment for the effective management of intravenous infusion
  • Market Challenges
    • Lack of skilled labor and product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Stromal Vascular Fraction Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stromal Vascular Fraction Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stromal Vascular Fraction Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stromal Vascular Fraction Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stromal Vascular Fraction Market

A detailed market share analysis in the Stromal Vascular Fraction Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stromal Vascular Fraction Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stromal Vascular Fraction Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stromal Vascular Fraction Market

A strategic analysis of the Stromal Vascular Fraction Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stromal Vascular Fraction Market, highlighting leading vendors and their innovative profiles. These include Cytori Therapeutics Inc., Hawaii Angels, Human Med AG, InGeneron, Inc., and Tissue Genesis.

Market Segmentation & Coverage

This research report categorizes the Stromal Vascular Fraction Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aspiration, Isolation, and Transfer.
  • Based on Application, market is studied across Cosmetic, Orthopedic, and Soft Tissue.
  • Based on End-Use, market is studied across Hospitals, Specialty Clinics, and Stem Cell Banks/Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research in pre-clinical and clinical investigations for regenerative medicine
      • 5.1.1.2. Rising surgeries for different diseases, including osteoarthritis and cartilage regeneration
      • 5.1.1.3. Growing cases of burn and skin diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of surgical devices for SVF
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations for new product launches for SVF
      • 5.1.3.2. Ongoing strategic investment for the effective management of intravenous infusion
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled labor and product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stromal Vascular Fraction Market, by Product

  • 6.1. Introduction
  • 6.2. Aspiration
  • 6.3. Isolation
  • 6.4. Transfer

7. Stromal Vascular Fraction Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic
  • 7.3. Orthopedic
  • 7.4. Soft Tissue

8. Stromal Vascular Fraction Market, by End-Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Specialty Clinics
  • 8.4. Stem Cell Banks/Laboratories

9. Americas Stromal Vascular Fraction Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stromal Vascular Fraction Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stromal Vascular Fraction Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cytori Therapeutics Inc.
  • 2. Hawaii Angels
  • 3. Human Med AG
  • 4. InGeneron, Inc.
  • 5. Tissue Genesis

LIST OF FIGURES

  • FIGURE 1. STROMAL VASCULAR FRACTION MARKET RESEARCH PROCESS
  • FIGURE 2. STROMAL VASCULAR FRACTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STROMAL VASCULAR FRACTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STROMAL VASCULAR FRACTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STROMAL VASCULAR FRACTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STROMAL VASCULAR FRACTION MARKET DYNAMICS
  • TABLE 7. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY SOFT TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STROMAL VASCULAR FRACTION MARKET SIZE, BY STEM CELL BANKS/LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STROMAL VASCULAR FRACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STROMAL VASCULAR FRACTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. STROMAL VASCULAR FRACTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. STROMAL VASCULAR FRACTION MARKET, FPNV POSITIONING MATRIX, 2023